Both Laboratory Corporation of America Holdings (NYSE:LH) and MYnd Analytics Inc. (NASDAQ:MYND) are Medical Laboratories & Research companies, competing one another. We will compare their institutional ownership, profitability, risk, analyst recommendations, dividends, earnings and valuation.

Valuation and Earnings

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Laboratory Corporation of America Holdings	11.33B	1.38	883.70M	8.75	16.81
MYnd Analytics Inc.	1.58M	7.30	9.28M	-1.41	0.00

Table 1 showcases the gross revenue, earnings per share and valuation of Laboratory Corporation of America Holdings and MYnd Analytics Inc.

Profitability

Table 2 provides the return on equity, return on assets and net margins of the two firms.

	Net Margins	Return on Equity	Return on Assets
Laboratory Corporation of America Holdings	7.80%	18%	7.6%
MYnd Analytics Inc.	-587.34%	0%	0%

Volatility and Risk

Laboratory Corporation of America Holdings has a 1.15 beta, while its volatility is 15.00%, thus making it more volatile than Standard & Poor’s 500. Competitively, MYnd Analytics Inc.’s beta is 3.31 which is 231.00% more volatile than Standard & Poor’s 500.

Liquidity

Laboratory Corporation of America Holdings’s Current Ratio is 1.6 while its Quick Ratio is 1.4. On the competitive side is, MYnd Analytics Inc. which has a 1.1 Current Ratio and a 1.1 Quick Ratio. Laboratory Corporation of America Holdings is better positioned to pay off short and long-term obligations compared to MYnd Analytics Inc.

Analyst Ratings

The following table delivered below contains the ratings and recommendations for Laboratory Corporation of America Holdings and MYnd Analytics Inc.

	Sell Ratings	Hold Ratings	Buy Ratings	Rating Score
Laboratory Corporation of America Holdings	1	3	7	2.64
MYnd Analytics Inc.	0	0	0	0.00

The upside potential is 7.49% for Laboratory Corporation of America Holdings with consensus price target of $170.89.

Institutional & Insider Ownership

Institutional investors owned 92.8% of Laboratory Corporation of America Holdings shares and 14.3% of MYnd Analytics Inc. shares. 0.4% are Laboratory Corporation of America Holdings’s share owned by insiders. On the other hand, insiders owned about 28.2% of MYnd Analytics Inc.’s shares.

Performance

In this table we provide the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

	Performance (W)	Performance (M)	Performance (Q)	Performance (HY)	Performance (Y)	Performance (YTD)
Laboratory Corporation of America Holdings	-0.05%	5.5%	-10.95%	-15.48%	-13.69%	16.35%
MYnd Analytics Inc.	10.89%	-5.4%	21.33%	-5.4%	-26.88%	128.74%

For the past year Laboratory Corporation of America Holdings was less bullish than MYnd Analytics Inc.

Summary

On 10 of the 12 factors Laboratory Corporation of America Holdings beats MYnd Analytics Inc.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates through two segments, LabCorp Diagnostics and Covance Drug Development. The company offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, tests for sexually-transmitted diseases, HCV tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens. It also provides specialty testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, and pain management; and esoteric testing, cancer diagnostics, and other complex procedures. In addition, the company provides drug development solutions, as well as laboratory testing services. Further, it provides its testing services through a sales force to the managed care organizations, biopharmaceutical companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, food and nutritional companies, and independent clinical laboratories. The company has collaboration with university, hospital and academic institutions, such as Duke University, Johns Hopkins University, Boston University, Columbia University, The Mount Sinai Hospital, the University of Tennessee, and Yale University to license and commercialize new diagnostic tests. Laboratory Corporation of America Holdings was founded in 1971 and is headquartered in Burlington, North Carolina.

MYnd Analytics, Inc. operates as a predictive analytics company. The company offers objective clinical decision support to mental healthcare providers for the personalized treatment of behavioral disorders, including depression, anxiety, bipolar disorder, post-traumatic stress disorder, and other non-psychotic disorders. The company uses its proprietary neurometric platform, PEER Online, to generate Psychiatric electroencephalogram (EEG) Evaluation Registry (PEER) reports to predict the likelihood of response by an individual to a range of medications prescribed for the treatment of behavioral disorders. Its PEER Online registry and reporting platform allows medical professionals to exchange treatment outcome data for patients referenced to objective neurophysiology data obtained through a standard EEG. MYnd Analytics, Inc. has collaborations with Horizon Healthcare Services, Inc., Hackensack Meridian Health, and Cota Inc. on a clinical study for the treatment of patients with depression. The company was formerly known as CNS Response, Inc. and changed its name to MYnd Analytics, Inc. in November 2015. MYnd Analytics, Inc. was founded in 2000 and is headquartered in Mission Viejo, California.